My ePortfolio Register   

Cellular pathways in lung cancer and the need for personalised medicine

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.11.11
Views: 4070

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

Prof Jean-Charles Soria talks to Prof Gordon McVie at NCRI 2011 discussing cellular pathways, the need for personalised medicine and new approaches to combination therapy.

Prof Soria stresses the need to molecularly distinguish lung cancer patients based on cellular pathways in order to treat them more effectively. This approach referred to as ‘personalised medicine’, looks at the patient’s molecular diagnosis to find the most appropriate drug.

Prof Soria feels that personalised medicine should create a context where the outcome of the patient is improved through identifying their molecular classifications and abnormalities, and then searching for a drug treatment best suited to that collective diagnosis.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence